260 related articles for article (PubMed ID: 22189417)
21. Risk index score for bacteremia in febrile neutropenic episodes in children with malignancies.
Spasova MI; Grudeva-Popova JG; Kostyanev SS; Genev ED; Stoyanova AA; Kirina VI; Moumdjiev IN
J BUON; 2009; 14(3):411-8. PubMed ID: 19810131
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of febrile, nonneutropenic pediatric oncology patients with central venous catheters who are not given empiric antibiotics.
Bartholomew F; Aftandilian C; Andrews J; Gutierrez K; Luna-Fineman S; Jeng M
J Pediatr; 2015 Jan; 166(1):157-62. PubMed ID: 25444524
[TBL] [Abstract][Full Text] [Related]
23. Increased T regulatory cells and decreased Th1 pro-inflammatory cytokines correlate with culture-positive infection in febrile neutropenia childhood oncology patients.
Hodge G; Scott J; Osborn M; To LB; Zola H; Hodge S; Revesz T
Cytokine; 2011 Mar; 53(3):286-8. PubMed ID: 21167738
[TBL] [Abstract][Full Text] [Related]
24. Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients.
Oude Nijhuis CSM; Vellenga E; Daenen SMGJ; van der Graaf WTA; Gietema JA; Groen HJM; Kamps WA; de Bont ESJM
Intensive Care Med; 2003 Dec; 29(12):2157-2161. PubMed ID: 14569424
[TBL] [Abstract][Full Text] [Related]
25. Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study.
El-Mahallawy H; Sidhom I; El-Din NH; Zamzam M; El-Lamie MM
Int J Infect Dis; 2005 Jan; 9(1):43-51. PubMed ID: 15603994
[TBL] [Abstract][Full Text] [Related]
26. Serum levels of IL-1 beta, sIL-2R, IL-6, IL-8, and TNF-alpha in febrile children with cancer and neutropenia.
Soker M; Colpan L; Ece A; Devecioğlu C; Haspolat K
Med Oncol; 2001; 18(1):51-7. PubMed ID: 11778970
[TBL] [Abstract][Full Text] [Related]
27. Mannose-binding lectin (MBL) and the risk for febrile neutropenia and infection in pediatric oncology patients with chemotherapy.
Frakking FN; Israëls J; Kremer LC; Kuijpers TW; Caron HN; van de Wetering MD
Pediatr Blood Cancer; 2011 Jul; 57(1):89-96. PubMed ID: 21557458
[TBL] [Abstract][Full Text] [Related]
28. Th1/Th2 cytokine profiles in G+/G- bacteremia in pediatric hematology/oncology patients.
Tang Y; Liao C; Xu X; Song H; Shi S; Yang S
Pediatr Blood Cancer; 2012 Jan; 58(1):50-4. PubMed ID: 22076831
[TBL] [Abstract][Full Text] [Related]
29. [Infective complications of the use of permanent central venous catheters in oncology].
Barriga F; Varas M; Capdeville MV; Sapunar F; Lira P; Grebe G
Rev Med Chil; 1992 Jul; 120(7):783-8. PubMed ID: 1341820
[TBL] [Abstract][Full Text] [Related]
30. Bacteremia in febrile nonneutropenic pediatric oncology patients.
Kelly MJ; Vivier PM; Panken TM; Schwartz CL
Pediatr Blood Cancer; 2010 Jan; 54(1):83-7. PubMed ID: 19774640
[TBL] [Abstract][Full Text] [Related]
31. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.
Engel A; Mack E; Kern P; Kern WV
Infection; 1998; 26(4):213-21. PubMed ID: 9717678
[TBL] [Abstract][Full Text] [Related]
32. Elevated serum cytokine levels using cytometric bead arrays predict culture-positive infections in childhood oncology patients with febrile neutropenia.
Badurdeen S; Hodge G; Osborn M; Scott J; St John-Green C; Tapp H; Zola H; Revesz T
J Pediatr Hematol Oncol; 2012 Jan; 34(1):e36-8. PubMed ID: 22215102
[TBL] [Abstract][Full Text] [Related]
33. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation.
Castagnola E; Fontana V; Caviglia I; Caruso S; Faraci M; Fioredda F; Garrè ML; Moroni C; Conte M; Losurdo G; Scuderi F; Bandettini R; Tomà P; Viscoli C; Haupt R
Clin Infect Dis; 2007 Nov; 45(10):1296-304. PubMed ID: 17968824
[TBL] [Abstract][Full Text] [Related]
34. Plasma copeptin in the assessment of febrile neutropenia.
Purhonen AK; Vänskä M; Hämäläinen S; Pulkki K; Lehtikangas M; Kuittinen T; Nousiainen T; Koivula I; Jantunen E; Juutilainen A
Peptides; 2012 Jul; 36(1):129-32. PubMed ID: 22580173
[TBL] [Abstract][Full Text] [Related]
35. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia.
Ammann RA; Hirt A; Lüthy AR; Aebi C
Pediatr Infect Dis J; 2004 Jan; 23(1):61-7. PubMed ID: 14743049
[TBL] [Abstract][Full Text] [Related]
36. Molecular-based diagnosis of bacteremia in the setting of fever with or without neutropenia in pediatric hematology-oncology patients.
Shachor-Meyouhas Y; Sprecher H; Moscoviz D; Zaidman I; Haimi M; Kassis I
J Pediatr Hematol Oncol; 2013 Oct; 35(7):500-3. PubMed ID: 24064965
[TBL] [Abstract][Full Text] [Related]
37. Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols.
Greenberg D; Moser A; Yagupsky P; Peled N; Hofman Y; Kapelushnik J; Leibovitz E
Int J Antimicrob Agents; 2005 Jun; 25(6):469-73. PubMed ID: 15890499
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 levels in febrile, young children with and without occult bacteremia.
Strait RT; Kelly KJ; Kurup VP
Pediatrics; 1999 Dec; 104(6):1321-6. PubMed ID: 10585983
[TBL] [Abstract][Full Text] [Related]
39. Repeating blood cultures in neutropenic children with persistent fevers when the initial blood culture is negative.
Rosenblum J; Lin J; Kim M; Levy AS
Pediatr Blood Cancer; 2013 Jun; 60(6):923-7. PubMed ID: 23047811
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 6, but not tumour necrosis factor-alpha, is a good predictor of severe infection in febrile neutropenic and non-neutropenic children with malignancy.
Abrahamsson J; Påhlman M; Mellander L
Acta Paediatr; 1997 Oct; 86(10):1059-64. PubMed ID: 9350884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
